Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype

Clinical trial NCT00001572 · COMPLETED

Trial details

NCT number: NCT00001572
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

B Cell Lymphoma Follicular Lymphoma Neoplasm

Start date: 1997-01-30
Primary completion: 1999-07-31
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.